Gsk (GLAXF) Current Leases (2016 - 2018)

Gsk's Current Leases history runs 3 years deep, the most recent figure standing at $30.9 million for Q4 2018.

• In Q4 2018, Current Leases rose 1.13% year-over-year to $30.9 million; the TTM figure through Dec 2018 stood at $30.9 million (up 1.13% YoY), while the FY2018 annual figure was $32.1 million, up 8.18% from the prior year.
• Current Leases was $30.9 million for Q4 2018 at Gsk, up from $30.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $30.9 million in Q4 2018 to a low of $28.6 million in Q4 2016.
• Historically, Current Leases has averaged $30.0 million across 3 years, with a median of $30.5 million in 2017.
• The sharpest annual moves came in 2017 and 2018: Current Leases advanced 6.79% in 2017, then gained 1.13% in 2018.
• A 3-year view of Current Leases shows it stood at $28.6 million in 2016, then advanced by 6.79% to $30.5 million in 2017, then gained by 1.13% to $30.9 million in 2018.
• The last three Current Leases figures came in at $30.9 million (Q4 2018), $30.5 million (Q4 2017), and $28.6 million (Q4 2016), per Business Quant data.